Titelia

Holdings of TCG Crossover Management, LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
46 in 4 countries
Top ten
62.5 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1ABIVAX SA 6,481,085721.7M $
2CG ONCOLOGY INC 3,670,206248.4M $
3Tango Therapeutics Inc 10,531,071220.3M $
4COGENT BIOSCIENCES INC 4,946,894190.4M $
5Centessa Pharmaceuticals PLC 4,286,480170.3M $
6Dianthus Therapeutics Inc 1,676,624140.7M $
7TYRA BIOSCIENCES INC 3,248,980124.4M $
8IMMUNOVANT INC 4,457,988110.7M $
9BioCryst Pharmaceuticals Inc 11,020,968104.9M $
10MIRUM PHARMACEUTICALS INC 1,062,04998.1M $
11VOR BIOPHARMA INC 5,673,07896.5M $
12Spyre Therapeutics Inc 1,900,58295.9M $
13AMYLYX PHARMACEUTICALS INC 6,243,81286.8M $
14Disc Medicine Inc 1,341,86285.8M $
15DYNE THERAPEUTICS INC 4,615,14483.7M $
16Monte Rosa Therapeutics Inc 4,622,15176M $
17SAVARA INC 12,362,20567.5M $
18REVOLUTION MEDICINES INC 576,47356.1M $
19Kodiak Sciences Inc 1,445,53855.1M $
20LB Pharmaceuticals Inc 1,839,48945.3M $
21Surrozen Inc 1,473,10142.9M $
22Relay Therapeutics Inc 4,273,35642.5M $
23FULCRUM THERAPEUTICS INC 5,250,00040.3M $
24Century Therapeutics Inc 17,754,43039M $
25Tectonic Therapeutic Inc 1,204,89137.2M $
26Perspective Therapeutics Inc 7,915,56733M $
27Xencor Inc 2,452,13829.6M $
28Entrada Therapeutics Inc 2,287,50028.9M $
29ALX Oncology Holdings Inc 13,011,84926.1M $
30Arvinas Inc 2,387,46125.3M $
31Janux Therapeutics Inc 1,789,61724.9M $
32AGOMAB THERAPEUTICS SA 2,053,23321.5M $
33Alector Inc 10,000,00021.5M $
34MBX BIOSCIENCES INC 650,00019.4M $
35SILENCE THERAPEUTICS PLC 3,033,56016M $
36Liquidia Corp 403,04815.2M $
37OCULAR THERAPEUTIX INC 1,647,75214M $
38AVALO THERAPEUTICS INC 738,38311M $
39Monopar Therapeutics Inc 132,1037.2M $
40Context Therapeutics Inc 2,682,6967M $
41STRUCTURE THERAPEUTICS INC 140,4116.8M $
42Cullinan Therapeutics Inc 406,7865.8M $
43Korro Bio Inc 416,3014.7M $
44LeonaBio Inc 464,3984.7M $
45Upstream Bio Inc 181,0631.6M $
46VISTAGEN THERAPEUTICS INC 2,676,5801.5M $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 72.7 %
  • France 21.2 %
  • United Kingdom 5.5 %
  • Belgium 0.6 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States422.5B $72.71 %
2France1721.7M $21.19 %
3United Kingdom2186.2M $5.47 %
4Belgium121.5M $0.63 %
Cite this page

Titelia. "Holdings of TCG Crossover Management, LLC". https://titelia.com/en/funds/US13F1839948